Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Sequential hemofiltration-hemodiafiltration technique: all in one?

M Amato1, A Brendolan, G Campolo

  • 1Nephrology Department, Prato Hospital, Prato, Italy.

Contributions to Nephrology
|May 7, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Vitamin D status and non-alcoholic fatty liver disease in patients with type 1 diabetes.

Journal of endocrinological investigation·2019
Same author

The E3 ubiquitin ligase WWP1 sustains the growth of acute myeloid leukaemia.

Leukemia·2017
Same author

Coronary Microvascular Dysfunction Predicts Long-Term Outcome in Simultaneous Pancreas-Kidney Transplantation.

Transplantation proceedings·2016
Same author

Purity and stability of online-prepared hemodiafiltration fluid after storage.

Blood purification·2013
Same author

Body composition and heart rate variability to achieve dry weight and tolerance.

Contributions to nephrology·2011
Same author

[A pilot study comparing pulse high volume hemofiltration (pHVHF) and coupled plasma filtration adsorption (CPFA) in septic shock patients].

Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia·2009
Same journal

Adsorption of Pathogens and Blockade of Sepsis Cascade.

Contributions to nephrology·2023
Same journal

Hemoadsorption: Research Agenda and Potential Future Applications.

Contributions to nephrology·2023
Same journal

Hemoperfusion in Poisoning and Drug Overdose.

Contributions to nephrology·2023
Same journal

Hemoperfusion in Burns.

Contributions to nephrology·2023
Same journal

Sequential Extracorporeal Therapy in Sepsis.

Contributions to nephrology·2023
Same journal

The Use of Adsorption in Extracorporeal Liver Support: The Double Plasma Molecular Adsorption System (DPMAS).

Contributions to nephrology·2023
See all related articles

Sequential hemofiltration/hemodiafiltration (SHF/HDF) is a feasible and promising dialysis technique. It improved patient well-being and reduced key markers like C-reactive protein, showing potential for enhanced quality of life.

Area of Science:

  • Nephrology
  • Renal Replacement Therapy
  • Dialysis Technology

Background:

  • Sequential dialysis techniques historically offered fluid removal without hemodynamic instability but declined due to inadequate dialysis and technological limitations.
  • Current advancements in online fluid preparation systems have revived interest in hemofiltration (HF) and hemodiafiltration (HDF).
  • Sequential hemofiltration/hemodiafiltration (SHF/HDF) aims to combine the benefits of HF and HDF while mitigating their respective drawbacks.

Purpose of the Study:

  • To evaluate the feasibility and effects of sequential hemofiltration/hemodiafiltration (SHF/HDF) in chronic hemodialysis patients.
  • To assess patient well-being and clinical markers during SHF/HDF therapy.

Main Methods:

  • A study involving 7 chronic hemodialysis patients.

Related Experiment Videos

  • Patients underwent 6 months of SHF/HDF followed by 6 months of sequential hemodiafiltration/hemofiltration (SHDF/HF).
  • Treatment utilized a specific machine (AK200 ULTRA) with an online fluid preparation system and a defined dialyzer (Polyflux 210).

    • Main Results:

    • The feasibility of both SHF/HDF and SHDF/HF techniques was excellent.
    • All treatment sessions resulted in patient well-being, enabling full-time work.
    • A significant reduction was observed in pre-treatment values of calcium-phosphorous product, C-reactive protein, and beta2-microglobulin.

    Conclusions:

    • SHF/HDF therapy is a highly promising approach for chronic hemodialysis.
    • The technique demonstrates excellent feasibility and patient tolerance.
    • Further research is warranted to fully explore its potential impact on quality of life, dialysis adequacy, and hemodynamic stability.